It is clinically important to recognize both bipolar disorder and borderline personality
disorder (BPD) in patients seeking treatment for depression, and it is important to distinguish …

Depression imposes significant costs on sufferers, their families and care-givers, employers
and insurance payers. This article summarises medical and health economics literature …

Context There is growing recognition that bipolar disorder (BPD) has a spectrum of
expression that is substantially more common than the 1% BP-I prevalence traditionally …

Objective: This study quantifies excess annual costs associated with schizophrenia patients
in the United States in 2002 from a societal perspective. Method: Annual direct medical costs …

Objective: Bipolar disorder, a serious illness resulting in significant psychosocial morbidity
and excess mortality, has been reported to be frequently underdiagnosed. However, during …

Background A number of data show the negative role of duration of untreated illness (DUI)
on outcome in mood disorders, but no investigation has been carried out about the impact of …

Objective: The purpose of this study was to examine comorbidities, treatment patterns, and
direct treatment costs of patients with bipolar disorder who are misdiagnosed with unipolar …

OBJECTIVE: Depression is frequent, underdiagnosed, and untreated in people with
epilepsy. The lack of treatment is partially explained by the concerns over the proconvulsive …

Objective: To determine the economic impact of bipolar disorder on health benefit costs and
health-related work absences from an employer perspective. Method: Data on health benefit …

Background: Several research reports have suggested that bipolar disorder is
underrecognized. Recommendations for improving the detection of bipolar disorder include …